Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
2855 GAZELLE COURT, CARLSBAD, CA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
21 Oct 2026

Ionis Pharmaceuticals, Inc. reported Regulation FD disclosure

Ionis Pharmaceuticals, Inc. filed an 8-K covering Regulation FD disclosure, another company event, supporting financial statements or exhibits.

23 Sep 2026

Ionis Pharmaceuticals, Inc. reported Regulation FD disclosure

Ionis Pharmaceuticals, Inc. filed an 8-K covering Regulation FD disclosure, another company event, supporting financial statements or exhibits.

5 Sep 2026

Ionis Pharmaceuticals, Inc. reported Regulation FD disclosure

Ionis Pharmaceuticals, Inc. filed an 8-K covering Regulation FD disclosure, another company event, supporting financial statements or exhibits.

4 Sep 2026

Ionis Pharmaceuticals, Inc. reported Regulation FD disclosure

Ionis Pharmaceuticals, Inc. filed an 8-K covering Regulation FD disclosure, another company event, supporting financial statements or exhibits.

31 Jul 2026

Ionis Pharmaceuticals, Inc. securities registration filing

Ionis Pharmaceuticals, Inc. filed a registration or prospectus document concerning securities.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$350.07M
Total assets (USD)$2.99B
Total liabilities (USD)$2.55B
Shareholders' equity (USD)$439.74M
Long-term debt (USD)$1.33B
Debt due within a year (USD)$432.12M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$267.95M−$102.29M−$114.65M−$0.6910-Q · 29 Jul 2026
Q1 2026$246.09M−$117.42M−$92.53M−$0.5610-Q · 29 Apr 2026
Q4 2025$203.33M−$214.46M−$229.39M−$1.4110-K · 26 Feb 2026
Q3 2025$156.72M−$160.18M−$128.61M−$0.8010-Q · 29 Oct 2025
Q2 2025$452.05M$139.82M$123.55M$0.7010-Q · 30 Jul 2025
Q1 2025$131.61M−$146.86M−$146.94M−$0.9310-Q · 30 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $83.26
84.6% upside potential
📈
Strong Buy
Unavailable
👍
Buy
17
⏸️
Hold
3
📉
Sell
0
20 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 54.00–104.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
16
Oct 2026
Devers Shannon L.
EVP, Chief Human Resources Ofc
Open-market sale
$43.54 per share
1,357 shares
SEC Form 4
16
Oct 2026
Swayze Eric
EVP Research
Open-market sale
$43.54 per share
53 shares
SEC Form 4
15
Oct 2026
Devers Shannon L.
EVP, Chief Human Resources Ofc
Option exercise
Unavailable per share
2,820 shares
SEC Form 4
15
Oct 2026
Swayze Eric
EVP Research
Option exercise
Unavailable per share
125 shares
SEC Form 4
31
Aug 2026
BENNETT C FRANK
EVP, Chief Scientific Officer
Other
$51.31 per share
110 shares
SEC Form 4
31
Aug 2026
O'NEIL PATRICK R.
EVP CLO & General Counsel
Other
$51.31 per share
63 shares
SEC Form 4
31
Aug 2026
Monia Brett P
Director, Chief Executive Officer
Other
$51.31 per share
98 shares
SEC Form 4
31
Aug 2026
Birchler Brian
EVP, Corp and Development Ops
Other
$51.31 per share
58 shares
SEC Form 4
31
Jul 2026
Hayden Michael R
Director
Open-market purchase
$51.60 per share
5,000 shares
SEC Form 4
30
Jul 2026
Hayden Michael R
Director
Open-market purchase
$53.38 per share
15,000 shares
SEC Form 4

Top Shareholders

Fmr Llc
24,631,956 shares
0.307% change
6/30/2026
Capital World Investors
21,669,226 shares
2.279% change
6/30/2026
Vanguard Group Inc
16,440,459 shares
-0.25% change
12/31/2025
Blackrock, Inc.
10,704,660 shares
2.511% change
6/30/2026
Vanguard Portfolio Management Llc
7,859,529 shares
0.648% change
6/30/2026
Wellington Management Group Llp
7,651,415 shares
19.706% change
6/30/2026
Vanguard Capital Management Llc
7,211,497 shares
1.309% change
6/30/2026
Two Sigma Investments, Lp
6,252,342 shares
6.738% change
6/30/2026
Royal Bank Of Canada
6,182,479 shares
62.619% change
6/30/2026
State Street Corp
4,334,848 shares
8.492% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 15 hours ago